Premium
ptx3, a key component of innate immunity, is induced by saa via fprl1‐mediated signaling in HAECs
Author(s) -
Dong Zhe,
An Fengling,
Wu Tingting,
Zhang Cheng,
Zhang Mingxiang,
Zhang Yun,
An Guipeng,
An Fengshuang
Publication year - 2011
Publication title -
journal of cellular biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 165
eISSN - 1097-4644
pISSN - 0730-2312
DOI - 10.1002/jcb.23128
Subject(s) - ptx3 , innate immune system , inflammation , serum amyloid a , pathogenesis , receptor , microbiology and biotechnology , immunology , biology , immune system , chemistry , medicine
Serum amyloid A (SAA) is regarded as an important acute phase protein in coronary artery diseases. However, its involvement in the immune response of atherosclerosis is poorly understood. The present study was designed to investigate the influence of SAA on the secretion of long pentraxin 3 (PTX3), a key component of innate immunity, in human aortic endothelial cells (HAECs). Our study revealed that recombinant SAA up‐regulated PTX3 production in a remarkable dose‐ and time‐dependent manner and the activation of formyl peptide receptor‐like 1 (FPRL1) was crucial for SAA‐induced expression of PTX3 in HAECs. Meanwhile, SAA‐induced PTX3 production could be significantly down‐regulated by using the specific siRNA sequences for Jun N‐terminal kinases (JNK). Furthermore, the activation of activator protein‐1 (AP‐1) was necessary for the up‐regulation of PTX3 expression. We also found that the activation of nuclear factor‐kappa B (NF‐κB) played an important role in this process. Our findings demonstrate that SAA up‐regulates PTX3 production via FPRL1 significantly, and thus, contributes to the inflammatory pathogenesis of atherosclerosis. J. Cell. Biochem. 112: 2097–2105, 2011. © 2011 Wiley‐Liss, Inc.